in the drug supply chain, in the case that such secretaries determine that changes to the standard format are necessary to prevent anticompetitive behavior. (c) Limitations on spread pricing (1) In general For plan years beginning on or after the date that is 30 months after the date of enactment of the Pharmacy Benefit Manager Reform Act , a group health plan shall ensure that the amount required to be paid by a participant or beneficiary for a prescription drug covered under the plan, and a third-party administrator or an entity providing pharmacy benefit management services on behalf of such a plan shall ensure that the total amount required to be paid by the plan and participant or beneficiary for a prescription drug covered under the plan, does not exceed the price paid to the pharmacy, excluding penalties paid by the pharmacy (as described in paragraph (2)) to such plan or entity. (2) Rule of construction For purposes of paragraph (1), penalties paid by pharmacies include only the following: (A) A penalty paid if an original claim for a prescription drug was submitted fraudulently by the pharmacy to the plan or entity. (B) A penalty paid if the original claim payment made by the plan or entity to the pharmacy was inconsistent with the reimbursement terms in any contract between the pharmacy and the plan or entity. (C) A penalty paid if the pharmacist services for which a claim was filed with the plan or entity were not rendered by the pharmacy. (d) Full rebate pass-through to plan (1) In general For plan years beginning on or after the date that is 30 months after the date of enactment of the Pharmacy Benefit Manager Reform Act , a third-party administrator of a group health plan or an entity providing pharmacy benefit management services on behalf of a group health plan shall— (A) remit 100 percent of rebates, fees, alternative discounts, and other remuneration received from any applicable entity that are related to utilization of drugs under such plan, to the group health plan